Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft

Objective: to study cognitive functions and level of proteins of acute brain damage in a group of patients receiving Cerebrolysin, and in a comparison group in the pre- and postoperative period of coronary artery bypass graft surgery.Materials and methods. The open-label randomized comparative contr...

Full description

Bibliographic Details
Main Authors: E. V. Lebedeva, A. S. Gorokhov, E. D. Schastnyy, A. N. Repin, G. G. Simutkin, E. V. Shishneva, V. A. Perchatkin, A. K. Surovtseva, S. Winter, R. S. Karpov, N. A. Bokhan
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2018-12-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
Online Access:https://bulletin.tomsk.ru/jour/article/view/1980
id doaj-a1a6fdc0404a45b8b52e373780497549
record_format Article
spelling doaj-a1a6fdc0404a45b8b52e3737804975492021-07-29T08:38:05ZengSiberian State Medical University (Tomsk)Bûlleten' Sibirskoj Mediciny1682-03631819-36842018-12-01174728410.20538/1682-0363-2018-4-72-841453Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graftE. V. Lebedeva0A. S. Gorokhov1E. D. Schastnyy2A. N. Repin3G. G. Simutkin4E. V. Shishneva5V. A. Perchatkin6A. K. Surovtseva7S. Winter8R. S. Karpov9N. A. Bokhan10Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS); Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Pediatrics Research Clinical Institute named after Аcademician Yu.E. Veltishchev of N.I. Pirogov, Russian National Research Moscow University (RNRMU)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Cardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)EVER Neuro Pharma GmbH OberburgauCardiology Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS)Mental Health Research Institute, Tomsk National Research Medical Center (TNRMC) of Russian Academy Sciences (RAS); Siberian State Medical University (SSMU) ; National Research Tomsk State University (NR TSU)Objective: to study cognitive functions and level of proteins of acute brain damage in a group of patients receiving Cerebrolysin, and in a comparison group in the pre- and postoperative period of coronary artery bypass graft surgery.Materials and methods. The open-label randomized comparative controlled parallel study included 60 men. The average age in the group of patients receiving the therapy with Cerebrolysin was 61.5 (57÷66) years, and was – 61 (56÷65) years (р > 0.05) in the comparison group.Results. Groups differed statistically significantly according to the left ventricular ejection fraction: 56 (48÷64) – in the group of comparison, 61 (59÷65) – in the group of patients receiving therapy with Cerebrolysin (p < 0.05). In the group of patients receiving Cerebrolysin, an increase in score according to MMSE (р < 0.01) was noted from 25 (24÷27) to 26.2 (24–28) points, and in the group without brain neuroprotection in the preoperative period a decrease in score according the Mini-Mental State Examination was revealed to be from 25.5 (25÷27) to 25 (23÷27) (р < 0.01). Clinical value of the level of protein S100ß as a biological indicator of postoperative cognitive dysfunction after cardiac surgery was ambiguous and required additional research.Conclusion. Brain neuroprotection with use of Cerebrolysin (authors’ schema) promoted not only maintenance but also improvement of cognitive functions and decreased the likelihood of complications in mental activity after coronary artery bypass graft surgery under conditions of artificial circulation and cold cardioplegia, particularly in patients with a high risk for their development.https://bulletin.tomsk.ru/jour/article/view/1980postoperative cognitive dysfunctioncoronary artery bypass graftprotein s100ßcerebrolysin
collection DOAJ
language English
format Article
sources DOAJ
author E. V. Lebedeva
A. S. Gorokhov
E. D. Schastnyy
A. N. Repin
G. G. Simutkin
E. V. Shishneva
V. A. Perchatkin
A. K. Surovtseva
S. Winter
R. S. Karpov
N. A. Bokhan
spellingShingle E. V. Lebedeva
A. S. Gorokhov
E. D. Schastnyy
A. N. Repin
G. G. Simutkin
E. V. Shishneva
V. A. Perchatkin
A. K. Surovtseva
S. Winter
R. S. Karpov
N. A. Bokhan
Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
Bûlleten' Sibirskoj Mediciny
postoperative cognitive dysfunction
coronary artery bypass graft
protein s100ß
cerebrolysin
author_facet E. V. Lebedeva
A. S. Gorokhov
E. D. Schastnyy
A. N. Repin
G. G. Simutkin
E. V. Shishneva
V. A. Perchatkin
A. K. Surovtseva
S. Winter
R. S. Karpov
N. A. Bokhan
author_sort E. V. Lebedeva
title Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
title_short Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
title_full Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
title_fullStr Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
title_full_unstemmed Time course of cognitive dysfunction and biochemical marker of CNS lesions S100ß in coronary artery bypass graft
title_sort time course of cognitive dysfunction and biochemical marker of cns lesions s100ß in coronary artery bypass graft
publisher Siberian State Medical University (Tomsk)
series Bûlleten' Sibirskoj Mediciny
issn 1682-0363
1819-3684
publishDate 2018-12-01
description Objective: to study cognitive functions and level of proteins of acute brain damage in a group of patients receiving Cerebrolysin, and in a comparison group in the pre- and postoperative period of coronary artery bypass graft surgery.Materials and methods. The open-label randomized comparative controlled parallel study included 60 men. The average age in the group of patients receiving the therapy with Cerebrolysin was 61.5 (57÷66) years, and was – 61 (56÷65) years (р > 0.05) in the comparison group.Results. Groups differed statistically significantly according to the left ventricular ejection fraction: 56 (48÷64) – in the group of comparison, 61 (59÷65) – in the group of patients receiving therapy with Cerebrolysin (p < 0.05). In the group of patients receiving Cerebrolysin, an increase in score according to MMSE (р < 0.01) was noted from 25 (24÷27) to 26.2 (24–28) points, and in the group without brain neuroprotection in the preoperative period a decrease in score according the Mini-Mental State Examination was revealed to be from 25.5 (25÷27) to 25 (23÷27) (р < 0.01). Clinical value of the level of protein S100ß as a biological indicator of postoperative cognitive dysfunction after cardiac surgery was ambiguous and required additional research.Conclusion. Brain neuroprotection with use of Cerebrolysin (authors’ schema) promoted not only maintenance but also improvement of cognitive functions and decreased the likelihood of complications in mental activity after coronary artery bypass graft surgery under conditions of artificial circulation and cold cardioplegia, particularly in patients with a high risk for their development.
topic postoperative cognitive dysfunction
coronary artery bypass graft
protein s100ß
cerebrolysin
url https://bulletin.tomsk.ru/jour/article/view/1980
work_keys_str_mv AT evlebedeva timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT asgorokhov timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT edschastnyy timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT anrepin timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT ggsimutkin timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT evshishneva timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT vaperchatkin timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT aksurovtseva timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT swinter timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT rskarpov timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
AT nabokhan timecourseofcognitivedysfunctionandbiochemicalmarkerofcnslesionss100ßincoronaryarterybypassgraft
_version_ 1721253275227914240